The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Heme oxygenase and carbon monoxide initiate homeostatic signaling
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
Li, J.-M., & Shah, A. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2004 · Cited by 773 · cited 1×
“There are four enzyme systems that dominate vascular ROS generation, including NAD(P)H oxidase, xanthine oxidase, uncoupled endothelial NOS (eNOS), and mitochondrial electron leakage [73–75].”
BackgroundRedox Redux: Revisiting PTPs and the Control of Cell Signaling
Tonks, N. K. (2005) · Cell · doi:10.1016/j.cell.2005.05.016 · Cited by 702
Baines, C. P., Goto, M., & Downey, J. M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0265 · Cited by 484 · cited 1×
“Although high concentrations of CO are toxic (as are all substances) and while there is excessive production of ROS by the mitochondria, inhibition of oxidative phosphorylation, and the generation of adenosine triphosphate (ATP) [46], recent reports continue to support that this generation of ROS at nondetrimental amo…”
BackgroundDrummond, G. R., Cai, H., Davis, M. E., Ramasamy, S., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.86.3.347 · Cited by 430 · cited 1×
“This induction may in fact be via an increase in H2O2, which has been reported [89, 90].”
BackgroundZuckerbraun, B. S., Chin, B. Y., Bilban, M., d'Avila, J. D. C., Rao, J., Billiar, T. R., & Otterbein, L. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-6644com · Cited by 323 · cited 1×
“The ability of CO to exert its effects and drive oxidative conditioning is contingent upon the rapid generation of ROS [27, 28, 37, 38].”
BackgroundSelf-citationMitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.
Zhang, J., & Piantadosi, C. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115980 · Cited by 320 · cited 1×
“Furthermore, ROS may act as possible “triggers” in the initiation of conditioning [42–46].”
BackgroundMitochondria, oxygen free radicals, and apoptosis
Raha, S., & Robinson, B. H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1398 · Cited by 306
Brouard, S., Berberat, P. O., Tobiasch, E., Seldon, M. P., Bach, F. H., & Soares, M. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108317200 · Cited by 306 · cited 2×
“CO can exhibit cell-specific anti-inflammatory [19], antiproliferative [20–22], and antiapoptotic effects [23, 24] by largely undetermined physiological mechanisms.”
BackgroundTaillé, C., El-Benna, J., Lanone, S., Boczkowski, J., & Motterlini, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503512200 · Cited by 246 · cited 4×
“In airway smooth muscle cells (ASMCs), CO inhibits platelet-derived growth factor (PDGF)-induced proliferation via an increase in mitochondrial ROS and subsequent inhibition of extracellular signal-regulated kinase (ERK) 1/2 phosphorylation and cyclin D1 expression, known to regulate proliferation [22].”
BackgroundInfluentialZhang, X., Shan, P., Alam, J., Fu, X.-Y., & Lee, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408092200 · Cited by 198
Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury
Zhang, X., Shan, P., Jiang, G., S‐M. Zhang, S., Otterbein, L. E., Fu, X., Le, P. J., Zhang, X., Shan, P., Jiang, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5668fje · Cited by 100 · cited 13×
“Therefore, ROS act as second messengers for CO signaling through induction of HIF1α and PPARγ before the stimulus as well as p38 MAPK, STAT, NF-κB, and numerous other genes poststimulus as listed in Figs.”
BackgroundInfluentialSelf-citation
Cited by
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
Self-citationCalabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 796
Heme oxygenase–1, oxidation, inflammation, and atherosclerosis
Araujo, J. A., Zhang, M., & Yin, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00119 · Cited by 443
“Interestingly, antiinflammatory effects are also mediated by activation of the MAPK signaling pathway, but they appear to require the generation of ROS as inhibition of ROS in macrophages leads to loss of CO antiinflammatory effects (Bilban et al., 2008).”
BackgroundMichel, B. W., Lippert, A. R., & Chang, C. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307017b · Cited by 433
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Metadata
- Authors
- Bilban, M., Haschemi, A., Wegiel, B., Chin, B. Y., Wagner, O., & Otterbein, L. E.
- Venue
- Journal of Molecular Medicine
- Published
- 2007-11-22
- Volume
- 86
- Issue
- 3
- Pages
- 267-279
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2171898271
- Cited by
- 241
- References
- 14
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.